Jun 05, 2017 - The company announced interim data for three ongoing cancer trials.
Jun 05, 2017 - A positive ASCO presentation for the experimental T-cell booster SD-101 is pushing Dynavax's shares higher today.
Jun 05, 2017 - Approvals of new drugs with nine-figure sales potential and a full pipeline that can fuel future growth make this stock increasingly appealing at these prices.
Jun 03, 2017 - Can animal-health stock Zoetis keep its red-hot momentum going?
May 31, 2017 - Looking for great dividend stocks of drugmakers with diabetes treatments? Check out AstraZeneca, Pfizer, and Sanofi.
May 31, 2017 - Gilead Sciences, Inc. (GILD) reported positive results on four phase III studies evaluating bictegravir in combination with FTC/TAF as a single tablet regimen for HIV infection.
May 31, 2017 - Aales of diabetes drugs from most large pharma companies slipped in the first quarter.
May 31, 2017 - Merck & Co., Inc. (MRK) recently announced that the FDA has approved Isentress HD, a new 1,200 mg once daily dose of its marketed drug Isentress (raltegravir), in combination with other anti-retroviral therapies.
May 26, 2017 - Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others
May 26, 2017 - The latest quarter gave investors in this dividend stock an encouraging glimpse into the future.